Contact Information
Company Information
Company
Quotient Therapeutics
Professional Summary
Rahul Kakkar serves as Chief Executive Officer at Quotient Therapeutics. Quotient Therapeutics operates in the research sector with approximately 76.0 employees. The company is headquartered in Boston, Massachusetts. Quotient Therapeutics generates annual revenue of 1100000.0. To date, Quotient Therapeutics has raised 50000000.0 in total funding, with the most recent round being Other.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
3,781 executive contacts are available in Massachusetts.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
ElasticEmail
Mimecast
Outlook
Microsoft Office 365
MailChimp
Google Tag Manager
Mobile Friendly
Vimeo
Greenhouse.io
Keywords
biotechnology research
somatic genomics
drug discovery
therapeutics
genomic variation
genetic mutations
disease pathology
clinical trials
phenotyping
genotyping
cellular selection
target identification
transformative medicines
genetic insights
drug development
clinical samples
single-molecule resolution
protein pathways
adaptive mutations
therapeutic modalities
biotech innovation
cell isolation
data-driven designs
genetic library
novel drug targets
clinical research
human genetics
variant sequencing
disease mechanisms
genomic sequencing
therapeutic development
intrinsic validation
cellular phenotypes
genetic disease
clinical applications
biotechnology
healthcare solutions
precision medicine
rare diseases
cancer genomics
genetic therapies
mutational landscapes
biopharmaceuticals
immunology
neurology
aging research
infectious diseases
cardiovascular diseases
cross-validation
research partnerships
data analysis
health care
health
wellness & fitness
hospital & health care
data analytics
Related Executives
Outreach Guidance — research Sector
Executives like Rahul Kakkar in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Quotient Therapeutics.
Rahul Kakkar's Position in the MessageCEO Database
- •Rahul Kakkar is 1 of 1 verified executive contact we track at Quotient Therapeutics.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •3,577 verified executive contacts in Massachusetts are in the database.
- •16 verified contacts work at research companies in the 76.0 employee range (same size as Quotient Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Rahul Kakkar directly?
Rahul Kakkar's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Quotient Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Rahul Kakkar work for?
Rahul Kakkar is Chief Executive Officer at Quotient Therapeutics, a company in the research sector with 76.0 employees. The company is based in Boston, Massachusetts.
Can I pitch or sell to Rahul Kakkar?
As Chief Executive Officer at Quotient Therapeutics, Rahul Kakkar is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Rahul Kakkar directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Rahul Kakkar in?
Rahul Kakkar works in the research industry as Chief Executive Officer at Quotient Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Rahul Kakkar's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rahul Kakkar's profile is kept up-to-date with the latest available information.
Last updated: July 18, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans